Surmodics

Elanco Animal Health (NYSE: ELAN) Stock Quote

Follow Insider Trades Visit website
Last Trade: US$9.22 0.62 7.21
Volume: 9,280,441
5-Day Change: 9.76%
YTD Change: -24.55%
Market Cap: US$4.540B

Latest News From Elanco Animal Health

May 25, 2023
Elanco Animal Health to Participate in Stifel 2023 Jaws and Paws Conference
GREENFIELD, Ind. / May 25, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Stifel 2023 Jaws and Paws Conference on Thursday, June 1, 2023. Todd Young, executive vice president and CFO, will participate in a fireside chat at 1:50 p.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website . A replay will be available for... Read More
May 9, 2023
Elanco Animal Health Reports First Quarter 2023 Results
First Quarter 2023 Financial Results Revenue of $1,257 million, including an estimated $90-$110 million benefit from customer purchasing shifted from the second quarter into the first as a result of ERP system commercial ordering blackout period for legacy Bayer Animal Health products in April Reported Net Income of $103 million, Adjusted Net Income of $220 million Adjusted EBITDA of $379 million or 30.2% of Revenue Reported... Read More
HealthStocksHub
May 2, 2023
Elanco Animal Health Announces Breakthrough Treatment for Deadly Canine Parvovirus
Targeted single-dose monoclonal antibody is the first and only treatment for devastating dog disease GREENFIELD, Ind. / May 02, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Department of Agriculture (USDA) has provided a conditional license for the first Canine Parvovirus... Read More
May 1, 2023
California Dairies and DSM Venturing Complete Strategic Investment in Athian
Athian's livestock carbon credit marketplace completes latest round of funding thanks to the investment by California Dairies, Inc. and DSM Venturing INDIANAPOLIS , May 1, 2023 /PRNewswire/ -- Athian ( athian.ai ) announces the completion of their seed funding round with investments from two strategic partners: DSM Venturing, the corporate venture arm of Royal DSM, a global, purpose-led company in Health, Nutrition &... Read More
April 18, 2023
Elanco Animal Health Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement
GREENFIELD, Ind. / Apr 18, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2023 financial results on Tuesday, May 9, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a... Read More
March 14, 2023
Tyson Ventures invests in Athian's cloud-based carbon credit marketplace for livestock sector
Will help fund ground-breaking solution to reward livestock producers for certified greenhouse gas reductions INDIANAPOLIS , March 14, 2023 /PRNewswire/ -- Athian (athian.ai), the world's first cloud-based carbon marketplace for the livestock industry, announces a seed investment from Tyson Ventures, the venture capital arm of Tyson Foods, Inc., one of the world's largest food companies and a recognized leader in protein.... Read More
March 9, 2023
Elanco Animal Health to Participate in the Barclays Global Healthcare Conference
GREENFIELD, Ind. / Mar 09, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Barclays Global Healthcare Conference on March 14-15, 2023. Todd Young, executive vice president and CFO, will participate in a fireside chat on Tuesday, March 14 at 8:30 a.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website . A replay will be... Read More
February 23, 2023
Elanco Animal Health to Participate in the Bank of America 2023 Animal Health Summit
GREENFIELD, Ind. / Feb 23, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Bank of America 2023 Animal Health Summit on Thursday, March 2, 2023. Jeff Simmons, president and CEO, and Todd Young, executive vice president and CFO, will represent the company and respond to questions from analysts at 4:40 p.m. ET. A live audio webcast will be available in the “Events and... Read More
February 21, 2023
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
GREENFIELD, Ind. / Feb 21, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year 2022, and provided initial guidance both for the first half and full year 2023. “Elanco’s 2022 results demonstrate our ongoing dedication to our Innovation, Portfolio, and Productivity (IPP) strategy, with significant advancement in our innovation pipeline... Read More
February 20, 2023
Elanco Adds Animal Health Veteran to Executive Committee
GREENFIELD, Ind. / Feb 20, 2023 / Business Wire / Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development. He will join Elanco’s executive committee on March 20. As Elanco shifts from the separation and stand up of the independent company and the integration of the Bayer Animal Health acquisition to an increasing... Read More
February 3, 2023
Elanco Animal Health Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
GREENFIELD, Ind. / Feb 03, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the... Read More
January 3, 2023
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 12:45 p.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website . A replay will be available for approximately 30... Read More
December 9, 2022
Elanco Animal Health Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
GREENFIELD, Ind.--( BUSINESS WIRE )--Today Elanco Animal Health (NYSE:ELAN) announced the U.S. Food and Drug Administration (FDA) approved Bexacat™ (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elanco’s innovative feline portfolio while addressing an unmet need for this chronic condition in adult cats. An estimated 600,000... Read More
C4 Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB